Werkgroep Cardiologische centra Nederland English

STANDUP-HF (Includerend)

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Ranging, Phase 2b Study of the Safety and Efficacy of Continuous 48-Hour Intravenous Infusions of BMS-986231 in Hospitalized Patients with HF and Impaired Systoli
Middel
BMS-986231
Populatie
hartfalen
Fase
II
Jaar aanvang
2016